Rapid PD-L1 detection in tumors with PET using a highly specific peptide-Reference-Cited by-同舟云学术

Rapid PD-L1 detection in tumors with PET using a highly specific peptide

Published:2017-01 Issue:1 Volume:483 Page:258-263
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Chatterjee Samit,Lesniak Wojciech G.,Miller Michelle S.,Lisok Ala,Sikorska Emilia,Wharram Bryan,Kumar Dhiraj,Gabrielson Matthew,Pomper Martin G.,Gabelli Sandra B.,Nimmagadda Sridhar^ORCID

Funder

Allegheny Health Network-Johns Hopkins Cancer Research Fund

NIH

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference24 articles.

1. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy;Topalian;Nat. Rev. Cancer,2016

2. Implications of programmed cell death 1 ligand 1 heterogeneity in the selection of patients with non-small cell lung cancer to receive immunotherapy;Mansfield;Clin. Pharmacol. Ther.,2016

3. Molecular imaging in drug development;Willmann;Nat. Rev. Drug Discov.,2008

4. PD-1 and PD-1 ligands: from discovery to clinical application;Okazaki;Int. Immunol.,2007

5. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients;Herbst;Nature,2014

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-signal output biosensor for the detection of program death-ligand 1 and therapy progress monitoring of cancer;Biosensors and Bioelectronics;2024-10

2. Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine;Chemical & Biomedical Imaging;2024-08-22

3. Bioorthogonal Diels–Alder Click Chemistry-Based Pretargeted PET Imaging Strategy for Monitoring Programmed Death-Ligand 1 Expression;ACS Omega;2024-08-21

4. Application of 99mTc-Labeled WL12 Peptides as a Tumor PD-L1-Targeted SPECT Imaging Agent: Kit Formulation, Preclinical Evaluation, and Study on the Influence of Coligands;Pharmaceuticals;2024-07-08

5. PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET;Frontiers in Immunology;2024-06-10